The Use of Transcatheter Laser Exposure in the Treatment of Cerebral Vessels Hypoplasia Accompanied by Migraine


The research is dedicated to the possibility of restoring cerebral blood supply in patients with brain vessels hypoplasia accompanied by migraine. The research involved 67 patients aged 29 - 58 (average age 42) with severe migraine. The examination plan included laboratory diagnostics, assessment of dementia severity (CDR), assessment of cognitive impairment (MMSE), cerebral computed tomography (CT), cerebral magnetic resonance imaging (MRI), cerebral scintigraphy (SG), rheoencephalography (REG), cerebral multi-gated angiography (MUGA). Hypoplasia symptoms were detected in 56 (83.58%) patients. To improve cerebral blood supply, the method of transcateter laser revascularization by means of low-energy CW lasers was used. Good immediate angiographic outcome manifested in persistent improvement of the intracranial vascular bed and marked collateral vascularization was obtained in 53 (94.64%) patients. Good clinical outcome— almost complete regression of migraine and vestibular disorders—was obtained in 49 (87.50%) patients. Satisfactory clinical outcome—partial regression of migraine and vestibular disorders— was observed in 7 (12.50%) patients. The method of transcatheter laser revascularization of cerebral vessels is a physiological, effective and low-invasive treatment for patients suffering from cerebral vessels hypoplasia accompanied by migraine. This method has virtually no alternative; it stimulates natural angiogenesis causing collateral and capillary vascularization steadily improving the blood supply of the brain. The effect obtained after the treatment persists for a long time (9 years and longer), it causes regression of migraine, reduces mental disorders, and can improve the patients’ quality of life.

Share and Cite:

Maksimovich, I. (2014) The Use of Transcatheter Laser Exposure in the Treatment of Cerebral Vessels Hypoplasia Accompanied by Migraine. Journal of Behavioral and Brain Science, 4, 443-452. doi: 10.4236/jbbs.2014.410043.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Guyuron, B., Reed, D., Kriegler, J.S., Davis, J., Pashmini, N. and Amini, S. (2009) A Placebo-Controlled Surgical Trial of the Treatment of Migraine Headaches. Plastic and Reconstructive Surgery, 124, 461-468.
[2] Bright, R., Bright, M., Bright, P., Hayne, S. and Thomas, W.D. (2014) Migraine and Tension-Type Headache Treated with Stromal Vascular Fraction: A Case Series. Journal of Medical Case Reports, 30, 237.
[3] Paemeleire, K., Louis, P., Magis, D., Vandenheede, M., Versijpt, J., Vandersmissen, B. and Schoenen, J. (2014) Diagnosis, Pathophysiology and Management of Chronic Migraine: A Proposal of the Belgian Headache Society. Acta Neurologica Belgica.
[4] Maksimovich, I.V. (2011) Transcatheter Laser Irradiation in the Treatment of Migraine. Journal of the American College of Cardiology, 58, 193-193.
[5] Alpaidze, M. and Beridze, M. (2014) Reversible Cerebral Vasoconstriction Syndrome and Migraine: Sonography Study. Georgian Medical News, 228, 28-36.
[6] Folkow, B. and Neil, E. (1971) Circulation. Oxford University Press, London-Toronto.
[7] Gjulev N.M., Pustozertsev, V.G. and Gjulev, S.N. (2002) Cerebrovascular Diseases. BINOM, Moscow.
[8] Luzha, D. (1973) X-Ray Anatomy of the Vascular System. Hungarian Academy of Sciences Publishing House, Budapest. http://рентгенхирургия.рф/?p=394
[9] Kelley, N.E. and Tepper, D.E. (2012) Rescue Therapy for Acute Migraine, Part 1: Triptans, Dihydroergotamine, and Magnesium. Headache, 52, 114-128.
[10] Kelley, N.E. and Tepper, D.E. (2012) Rescue Therapy for Acute Migraine, Part 2: Neuroleptics, Antihistamines, and Others. Headache, 52, 292-306.
[11] Kelley, N.E. and Tepper, D.E. (2012) Rescue Therapy for Acute Migraine, Part 3: Opioids, NSAIDs, Steroids, and Post-Discharge Medications. Headache, 52, 467-482.
[12] Orr, S.L., Aubé, M., Becker, W.J., Davenport, W.J., Dilli, E., Dodick, D., et al. (2014) Canadian Headache Society Systematic Review and Recommendations on the Treatment of Migraine Pain in Emergency Settings. Cephalalgia, Epub ahead of print.
[13] Morris, J.C. (1993) The Clinical Dementia Rating (CDR): Current Version and Scoring Rules. Neurology, 43, 2412-2414.
[14] Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975) “Mini-Mental State”. A Practical Method for Grading the Cognitive State of Patients for the Clinician. Journal of Psychiatric Research, 12, 189-198.
[15] Maksimovich, I.V. (2006) Method for Carrying out Transluminal Laser-Induced Brain Revascularization in Atherosclerotic Injury Cases. RF Patent No. 2297861.
[16] Maksimovich, I.V. (2007) Method of Transluminal Laser Revascularization of Cerebral Blood Vessels Having Atherosclerotic Lesions. US Patent No. 7490612.
[17] Maksimovich, I.V. (2004) Transljuminalnaja a Laser Angioplasty in Treatment of Ischemic Lesions of a Brain. M.D. Dissertation, Russian University of Friendship of the People, Moscow.
[18] Kuleshov, E.V. and Maksimovich, I.V. (1994) Endovascular Surgery in Patients over 65 with Disseminated Atherosclerosis of the Vessels of the Pelvis and Lower Extremities. Vestnik khirurgii imeni I. I. Grekova, 152, 27-30.
[19] Maksimovich, I.V. (2012) Transcatheter Treatment of Atherosclerotic Lesions of the Brain Complicated by Vascular Dementia Development. World Journal of Neuroscience, 2, 200-209.
[20] Maksimovich, I.V. (2013) Possibilities of Transcatheter Treatment of Patients after Extensive Ischemic Stroke. World Journal of Neuroscience, 3, 171-185.
[21] Maksimovich, I.V. (2013) TCT-508 Transcatheter Treatment of Patients after Extensive Ischemic Stroke. Journal of the American College of Cardiology, 62, B155.
[22] Hashmi, J.T., Huang, Y.Y., Osmani, B.Z., Sharma, S.K., Naeser, M.A. and Hamblin, M.R. (2010) Role of Low-Level Laser Therapy in Neurorehabilitation. PM&R, 2, S292-S305.
[23] Naeser, M.A. and Hamblin, M.R. (2011) Potential for Transcranial Laser or LED Therapy to Treat Stroke, Traumatic Brain Injury, and Neurodegenerative Disease. Photomedicine and Laser Surgery, 29, 443-446.
[24] Song, S., Zhou, F. and Chen, W.R. (2012) Low-Level Laser Therapy Regulates Microglial Function through Src-Mediated Signaling Pathways: Implications for Neurodegenerative Diseases. Journal of Neuroinflammation, 9, 219.
[25] Konstantinovic, L.M., Jelic, M.B., Jeremic, A., Stevanovic, V.B., Milanovic, S.D. and Filipovic, S.R. (2013) Transcranial Application of Near-Infrared Low-Level Laser Can Modulate Cortical Excitability. Lasers in Surgery and Medicine, 45, 648-653.
[26] Yang, X., Askarova, S., Sheng, W., Chen, J.K., Sun, A.Y., Sun, G.Y., Yao, G. and Lee, J.C.M. (2010) Low Energy Laser Light (632.8 nm) Suppresses Amyloid-β Peptide-Induced Oxidative and Inflammatory Responses in Astrocytes. Neuroscience, 171, 859-868.
[27] Barrett, D.W. and Gonzalez-Lima, F. (2013) Transcranial Infrared Laser Stimulation Produces Beneficial Cognitive and Emotional Effects in Humans. Neuroscience, 230, 13-23.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.